Buchumschlag

Concerns about conclusions of the POLAR trial: reply

In Reply We thank Ventzel and colleagues for their thoughtful commentary on our recent article. While we respectfully disagree with several of the points raised, we appreciate the opportunity to address these concerns and clarify aspects of our methodology and interpretation.Chemotherapy-induced per...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Michel, Laura L. (VerfasserIn) , Müller, Jana (VerfasserIn) , Weiler, Markus (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: July 31, 2025
In: JAMA oncology
Year: 2025, Jahrgang: 11, Heft: 9
ISSN:2374-2445
DOI:10.1001/jamaoncol.2025.2358
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/jamaoncol.2025.2358
Verlag, lizenzpflichtig, Volltext: https://jamanetwork.com/journals/jamaoncology/article-abstract/2837084#250563672
Volltext
Verfasserangaben:Laura L. Michel, Jana Müller, Markus Weiler

MARC

LEADER 00000naa a2200000 c 4500
001 1943099952
003 DE-627
005 20251202133223.0
007 cr uuu---uuuuu
008 251202s2025 xx |||||o 00| ||eng c
024 7 |a 10.1001/jamaoncol.2025.2358  |2 doi 
035 |a (DE-627)1943099952 
035 |a (DE-599)KXP1943099952 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Michel, Laura L.  |d 1984-  |e VerfasserIn  |0 (DE-588)1018124888  |0 (DE-627)680395857  |0 (DE-576)355064529  |4 aut 
245 1 0 |a Concerns about conclusions of the POLAR trial  |b reply  |c Laura L. Michel, Jana Müller, Markus Weiler 
264 1 |c July 31, 2025 
300 |a ? 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.12.2025 
520 |a In Reply We thank Ventzel and colleagues for their thoughtful commentary on our recent article. While we respectfully disagree with several of the points raised, we appreciate the opportunity to address these concerns and clarify aspects of our methodology and interpretation.Chemotherapy-induced peripheral neuropathy (CIPN) can affect both the feet and hands, leading to distinct functional impairments and different types of interference with daily activities and health-related quality of life (QoL). Whereas symptoms in the feet typically affect balance and walking, symptoms in the hands more commonly affect fine motor skills. To our knowledge, there is no evidence suggesting that symptoms in the feet have a greater (or lesser) affect on activities of daily living or QoL. This is likely highly individual depending on factors such as profession (eg, mail carrier vs jewelry maker) or leisure activities (eg, runner vs harpist). 
700 1 |a Müller, Jana  |d 1988-  |e VerfasserIn  |0 (DE-588)120824969X  |0 (DE-627)1694487504  |4 aut 
700 1 |a Weiler, Markus  |d 1972-  |e VerfasserIn  |0 (DE-588)123920256  |0 (DE-627)706474236  |0 (DE-576)293943079  |4 aut 
773 0 8 |i Enthalten in  |t JAMA oncology  |d Chicago, Ill. : American Medical Association, 2015  |g 11(2025), 9, Artikel-ID 1098  |h Online-Ressource  |w (DE-627)818494301  |w (DE-600)2810928-4  |w (DE-576)426501284  |x 2374-2445  |7 nnas  |a Concerns about conclusions of the POLAR trial reply 
773 1 8 |g volume:11  |g year:2025  |g number:9  |g elocationid:1098  |g extent:?  |a Concerns about conclusions of the POLAR trial reply 
787 0 8 |i Ergänzung zu  |a Ventzel, Lise  |t Concerns About Conclusions of the POLAR Trial, in JAMA oncology  |d 2025, volume 11, issue 9  |o 10.1001/jamaoncol.2025.2355 
856 4 0 |u https://doi.org/10.1001/jamaoncol.2025.2358  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://jamanetwork.com/journals/jamaoncology/article-abstract/2837084#250563672  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251202 
993 |a Editorial 
994 |a 2025 
998 |g 123920256  |a Weiler, Markus  |m 123920256:Weiler, Markus  |d 910000  |d 911100  |d 50000  |e 910000PW123920256  |e 911100PW123920256  |e 50000PW123920256  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 3  |y j 
998 |g 120824969X  |a Müller, Jana  |m 120824969X:Müller, Jana  |d 910000  |d 910100  |e 910000PM120824969X  |e 910100PM120824969X  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1018124888  |a Michel, Laura L.  |m 1018124888:Michel, Laura L.  |d 910000  |d 910100  |e 910000PM1018124888  |e 910100PM1018124888  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1943099952  |e 4818516732 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1001/jamaoncol.2025.2358"],"eki":["1943099952"]},"name":{"displayForm":["Laura L. Michel, Jana Müller, Markus Weiler"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 02.12.2025"],"title":[{"subtitle":"reply","title_sort":"Concerns about conclusions of the POLAR trial","title":"Concerns about conclusions of the POLAR trial"}],"origin":[{"dateIssuedDisp":"July 31, 2025","dateIssuedKey":"2025"}],"person":[{"family":"Michel","given":"Laura L.","role":"aut","display":"Michel, Laura L."},{"given":"Jana","role":"aut","family":"Müller","display":"Müller, Jana"},{"family":"Weiler","given":"Markus","role":"aut","display":"Weiler, Markus"}],"relHost":[{"recId":"818494301","physDesc":[{"extent":"Online-Ressource"}],"disp":"Concerns about conclusions of the POLAR trial replyJAMA oncology","origin":[{"publisherPlace":"Chicago, Ill.","dateIssuedKey":"2015","dateIssuedDisp":"2015-","publisher":"American Medical Association"}],"title":[{"title_sort":"JAMA oncology","title":"JAMA oncology"}],"note":["Gesehen am 12.10.2017"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"pubHistory":["1.2015 -"],"corporate":[{"role":"isb","display":"American Medical Association"}],"part":{"year":"2025","issue":"9","text":"11(2025), 9, Artikel-ID 1098","volume":"11","extent":"?"},"id":{"eki":["818494301"],"issn":["2374-2445"],"zdb":["2810928-4"]}}],"physDesc":[{"extent":"? S."}],"recId":"1943099952"} 
SRT |a MICHELLAURCONCERNSAB3120 

Ähnliche Einträge